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de.pt (M.C. Botelho).We have previously identiﬁed the expression of an estradiol (E2)-related molecule by Schistosoma hae-
matobium total antigen (Sh). We now show that this molecule has an antagonistic effect of estradiol
in vitro. Our results are consistent with the existence of an estrogenic molecule that antagonizes the
activity of estradiol. We found evidence for this molecule as we identiﬁed and characterized by mass
spectrometry new estrogenic molecules previously unknown, present in schistosome worm extracts
and sera of Schistosoma-infected individuals. We also show that Sh is able to interact in vitro with estro-
gen receptor (ER), explaining how host endocrine system can favor the establishment of schistosomes.
These ﬁndings highlight the exploitation of the host endocrine system by schistosomes and represent
an additional regulatory component of schistosome development that deﬁnes a novel paradigm enabling
host–parasite interactions. The identiﬁcation of these molecules opens new ways for the development of
alternative drugs to treat schistosomiasis.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Despite affecting 200 million people, schistosomiasis remains a
neglected disease. There are twomain reasons for this: the availabil-
ity of an effective and cheap drug, praziquantel, has contributed to
the wrong perception that chemotherapy would represent the ﬁnal
solution for the control of schistosomiasis, and the disability
adjusted life years as a measure of the impact of disease has been
under evaluated because of rebound morbidity following chemo-
therapeutic intervention (Capron et al., 2005). Prevalence is thought
to be risingmainly due to increasing travelers from theUSA and Eur-
ope to these endemic regions for business or leisure. Wars are also
known to increase the impact of schistosomiasis as demonstrated
by a case recently published by our group (Vieira et al., 2007).ll rights reserved.
Health, CIBP, Rua Alexandre
223401109.
onica.botelho@insa.min-sauThe mechanisms by which host hormones act on parasites have
recently been investigated, and some parasite molecules that are
involved in transregulation have been identiﬁed and characterized.
In the case of schistosomes, hormonal signals from the host seem
to have a major inﬂuence on larval homing, survival, growth and
sexual maturation (Mendonça et al., 2000; Escobedo et al., 2005).
In the case of schistosomes, some hormonal signals from the host
seem to have a major inﬂuence on larval homing, survival, growth,
and sexual maturation. Moreover, this is a 2-way dialogue and cer-
tain helminth parasites can have a particularly marked effect on
the fecundity of the host (Mendonça et al., 2000).
Nuclear hormone receptors comprise a large superfamily of
transcription factors whose activity is under hormonal control.
These receptors are characterized by a central DNA-binding
domain, which interacts with speciﬁc hormone response elements
located near the target gene promoter, and by two distinct activa-
tion function (AF) domains that contribute to the transcriptional
activity of these receptors (Delage-Mourroux et al., 2000).
The estrogen receptor (ER), a member of the steroid receptor
family, mediates the stimulatory effects of estrogens and the
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et al., 2000). Estrogen receptor (ER), mediates the biological effects
of estrogens in a variety of target tissues (Delage-Mourroux et al.,
2000) and ER-regulated genes are involved in many biological pro-
cesses, including cell growth and differentiation, morphogenesis,
and programmed cell death (Martini et al., 2000). The bound estro-
gen receptor stimulates transcription via interaction with the
estrogen response element (ERE) in the nucleus (Catherino and Jor-
dan, 1995).
We recently reported the expression of an estradiol-like mole-
cule by a trematode parasite Schistosoma haematobium (Botelho
et al., 2009). To better understand the mechanism by which this
molecule works, we transfected CHO cells with an expression plas-
mid containing an ERE linked to a luciferase and treated the cells
with S. haematobium total antigen (Sh). In this way, as we show in
this paper, we identiﬁed interaction of Sh with the ER. Intriguingly,
we found that the estradiol-like molecule is an antagonist of estra-
diol, repressing the transcriptional activity of the ER. To better char-
acterize this molecule we recurred the technique of mass
spectrometry and developed a new method for the detection of
estrogenic molecules in biologic samples. In this way, as we show
in this paper, we identiﬁed new estrogenic molecules in S. haemat-
obium total antigen as well as in the serum of infected individuals
with this parasitic disease that seem to be speciﬁc of this parasite.
Elucidating the role of estrogens signaling pathway during S.
haematobium infection will determine the use of new drug targets
to treat this disease.2. Materials and methods
2.1. Animals
Eight-week-old female golden hamsters (LVG/SYR) were pro-
vided by Charles River (Barcelona, Spain). Animals spent one week
being acclimated under routine laboratory conditions before start-
ing the experiments. They did not receive any treatment prior to
the study. Hamsters were kept in separated cages and fed standard
balanced food and water ad libitum. All the animals were raised
and maintained at the National Institute of Health (Porto, Portugal)
in rooms with controlled temperature (22 ± 2 C) and humidity
(55% ± 10%) and continuous air renovation. Animals were housed
in a 12 h light/12 h dark cycle (8 am to 8 pm). All animal experi-
ments were performed in accordance with the National (DL 129/
92; DL 197/96; P 1131/97) and European Convention for the
Protection of Animals used for Experimental and Other Scientiﬁc
Purposes and related European Legislation (OJ L 222, 24.8.1999).
2.2. Parasites
Schistosoma haematobium (Angolan strain) life cycle was main-
tained through successive passages in laboratory-raised Bulinus
truncatus as invertebrate hosts and golden hamsters as vertebrate
hosts. Cercariae of S. haematobium were obtained from infected
snails by the use of artiﬁcial light.
2.3. Experimental infections
Urine was collected from S. haematobium-infected individuals.
The individuals were living in Angola, an endemic area for schisto-
somiasis. Following instruction in midstream urine collection, ur-
ine samples were then collected from each individual. S.
haematobium infection was detected by microscopically observa-
tion of the eggs in the sediment of centrifuged urine. Informed
consent from patients was obtained. The eggs were hatched and
with the resulting miracidia, snails from susceptible species wereinfected. Golden hamsters were experimentally infected with 100
cercariae by tail immersion. The control animals consisted of litter-
mates. The cercariae were obtained by shedding of snails infected
with miracidia.
2.4. Schistosoma haematobium total antigen production
Schistosoma haematobium adult worms were collected by perfu-
sion of the hepatic portal system of golden hamsters at seven
weeks after infection with 100 cercariae. The worms were sus-
pended in PBS and then sonicated. The protein extract was then
ultracentrifuged (20,000 RPM) and the protein concentration was
estimated using a micro BCA protein assay reagent kit.
2.5. Sera
Sera from S. haematobium-infected individuals were obtained
from CIBP (INSA-Porto). All sera were selected on the basis of posi-
tive urine egg counts for S. haematobium.
2.6. Chemicals and materials
CHO cells were cultured in CHO medium (Sigma Aldrich, Portu-
gal) and MCF-7 cells were cultured in RPMI 1640 medium phenol
red free (Sigma Aldrich, Portugal), with 10% fetal bovine serum
(FBS) and 1% penicillin/streptomycin, purchased in Invitrogen Life
Technologies (Paisley, Scotland, UK). Estradiol (E2) was obtained
from Sigma Aldrich (Portugal) and the antiestrogen ICI 182,780
(ICI) was kindly provided by AstraZeneca (Portugal), both chemi-
cals dissolved in 100% ethanol and added to cell culture medium.
2.7. Plasmids
Plasmids were used to transform DH5a Escherichia coli. Individ-
ual colonies were isolated and plasmid miniprep was done using
the Promega Miniprep Kit. The desired plasmid was ampliﬁed
and isolated using the Qiagen maxiprep kit. The estrogen-respon-
sive reporter plasmid, pERE-Luc, was kindly provided by Ming Tsai
and Bert O’Malley (Baylor College of Medicine, Houston, TX)
(Nawaz et al., 1999).
2.8. Cell culture
CHO cells and MCF-7 cells were maintained at 37 C in a 5% CO2
humidiﬁed atmosphere. Cells were passaged every 5 days. Before
treatments cells were serum-starved for 16 h. The cells were trea-
ted with Sh antigen for 24 h in serum-free conditions.
2.9. Estradiol assay
CHO cells were cultured in 0.3 ml CHO media in 24-well ﬂat-
bottomed plates. Cultures were seeded at 5  104 cells/well and al-
lowed to attach overnight. Cells were then treated with increasing
concentrations of Sh for 24, 48 and 72 h. Estradiol in the superna-
tant of CHO cells was determined using electrochemiluminescence
(ECLIA) with the Immulite 2000 Analyser (DPC) and ELISA (Calbio-
tech) according to the manufacturer’s instructions.
2.10. Lactoferrin assay
MCF-7 cells were cultured in 0.3 ml RPMI medium in 24-well
ﬂat-bottomed plates. Cultures were seeded at 5  104 cells/well
and allowed to attach overnight. Cells were then treated with
50 lg/ml of Sh for 24 h. Lactoferrin in the supernatant of MCF-7
cells was determined using ELISA with an antibody speciﬁc for
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instructions.2.11. Isolation of RNA
At deﬁned time intervals MCF-7 cultured cells were harvested
in Tripure reagent (Roche, Portugal). Total RNA was isolated from
the cell material according to the manufacture instructions. RNA
recovery and quality were checked by measuring the optical den-
sity ratio (260/280 nm) and its quantiﬁcation was determined also
by optical density (Nanodrop).2.12. Real-Time PCR
Real-Time PCR was performed in MCF-7 cultures. For this pur-
pose cDNA was obtained using the Promega cDNA kit. For each
sample, 1.0 lg of RNA was reverse transcribed in a reaction volume
of 20 ll in the presence of 10 mM deoxynucleotide triphosphate
and 2 ll RT-PCR enzyme mix. Taqman GeneExpression assays (Ap-
plied biosystems) were used for gene-speciﬁc primers and probes
for ER alpha (ESR1, assay ID Hs 01046817_m1, PE Applied Biosys-
tems, USA) and ER beta (ESR2, assay ID Hs 00230957_m1, PE Ap-
plied Biosystems, USA). Both target gene transcripts were
normalized to the reference gene GAPDH mRNA (assay ID Hs
99999905_m1, PE Applied Biosystems, USA) content and to the
control sample. Quantiﬁcations were done in triplicate in a 7500
Real-Time PCR System (PE Applied Biosystems, USA).2.13. Transient transfection
CHO cells were plated for transfection in 24-well plate and
incubated for 24 h at 37 C with 5% CO2 the day before transfection.
The cells were transfected with 0.75 lg ERE-Luc plasmid per well
and 0.3 lg pCMV-b (which constitutively produces b-galactosi-
dase) for normalization. Cells were transfected by using Lipofect-
amine (Invitrogen, Carlsbad, California, USA) according to the
manufacturer’s recommended guidelines. Cells were washed and
fed with CHO medium and subsequently treated with 50 lg/ml
of Sh, 109 E2 and 109 M ICI. Concentrations for E2 and ICI used
were based on previous studies (Soares et al., 2003). As a control,
cells were treated with vehicle alone (ethanol). After 24 h, cells
were harvested and cell extract were prepared for luciferase assay.
Luciferase activity was determined using an enhanced luciferase
assay kit (BD Biosciences, USA) in a scintillation counter (Amer-
sham Biosciences, USA). Cell extracts were assayed for b-galactosi-
dase activity as described previously (MacGregor and Caskey,
1989), and the luciferase units were normalized to b-galactosidase
activity from the cotransfected pCMV-b internal reference plasmid.0
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Fig. 1. Estradiol production in culture of S. haematobium total antigen treated CHO
cells. The experiments were done in triplicate (*p < 0.01; 50, 100 and 200 lg/ml vs.
control) for days 1, 2 and 3. We used the concentration of 50 lg/ml of Sh for the
subsequent assays.2.14. Mass spectrometry analysis
LC–MS analysis were carried out using a Thermo Finnigan Sur-
veyor LCQ DECA XP MAX quadrupole ion trap mass spectrometer,
utilizing electrospray ionization, coupled to a LC of Thermo Finni-
gan. UV detection was achieved at 280 nm and the column was a
Merck Purospher STAR RP-18e 125 cm  4.6 (3 lm), equipped with
a Merck Lichrocart pre-column (Merck, Germany).
The mobile phases consisted of water/acetonitrile/acetic acid
mixtures, 95:5:0.5 for A and 45:55:0.5 for B. The following gradient
was 0–5 min, 100% A; 5–10 min, linear gradient from 100% to 80%
A; 10–15 min, 80% A; 15–50 min, linear gradient from 80% to 40%
A; 50–65 min, 40% A; 65–75 min, linear gradient from 40% A to
100% B. The ﬂow rate was 0.5 mL/min and for MS2 experiments,
the collision energy was optimized at 30%.2.15. Statistical analysis
Data were expressed as mean ± SD. t-Test was used to assess the
statistical signiﬁcance of differences. p < 0.05 was considered sta-
tistically signiﬁcant.3. Results
3.1. Schistosoma haematobium total antigen decreases estradiol
production of CHO cells in vitro
Since we discovered that Sh expresses a molecule analogue to
estradiol (Botelho et al., 2009), we developed an assay to conﬁrm
the estradiol-like effect on estrogen responsive cells. Here we eval-
uate the production of estradiol by these cells, since estradiol pro-
duction is a target of estradiol itself. For this purpose, CHO cells
were seeded on 96 well plates, starved ON, treated with increasing
concentrations of S. haematobium total antigen (Sh) for 24 h, cul-
tured for 24, 48 and 72 h and their supernatants analyzed by ECLIA.
Surprisingly, the curve shows that cells treated with Sh at a con-
centration of 50 lg/ml or higher decreased signiﬁcantly estradiol
production in comparison to control cells (Fig. 1).
3.2. Schistosoma haematobium total antigen is an antagonist of
estradiol
To further elucidate the previous results, we analyzed the ef-
fects of estradiol (E2), ICI 182,780 (ICI) and Sh on estradiol produc-
tion in CHO cells. Serum-starved cells in six-well plates were
treated with 109 M E2, 109 M ICI or 50 lg/ml of Sh for 24 h.
Supernatants were analyzed by ELISA. We observed, as expected,
that ICI reverts estrogen release to the supernatant (E2 + ICI com-
pared to E2 bars). Surprisingly, Sh decreases signiﬁcantly estradiol
level in supernatant to a higher extent than ICI. These ﬁndings
demonstrate an antagonist effect of estradiol. Remarkably, co-cul-
turing Sh with ICI reverts the decrease of estradiol induced by Sh,
demonstrating that this effect is probably mediated by estrogen
receptor (Fig. 2).
3.3. Schistosoma haematobium total antigen reduces the production of
lactoferrin in the supernatant of MCF-7 cells
Lactoferrin is a target gene of estrogen receptor and can be a
useful marker of estrogen action on estrogen responsive cells like
MCF-7. Therefore MCF-7 cells were seeded on 96 well plates,
starved ON, treated with 50 lg/ml of Sh for 24 h, cultured for 24
and 48 h, and the supernatants analyzed by ELISA for lactoferrin
(Fig. 3). Bars show that Sh-treated cells produced less lactoferrin
than control cells. In addition, incubation with ICI or Sh + ICI also
led to identical decrease in lactoferin secretion (*p < 0.05 vs
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Fig. 2. Estradiol production in supernatant of CHO cells. Cells were treated with 10–
9 M of E2, 10–9 M of ICI and 50 mg/ml of Sh. Data represent means ± SEM from
three independent experiments (*p < 0.05 Sh vs. control).
Fig. 4. Real-Time PCR for ER alpha and ER beta in MCF-7 cells. Bars correspond to
fold increase of ER alpha and ER beta gene expression after normalization to
endogenous control gene GAPDH and control sample. Results are representative of
three independent experiments. Statistically signiﬁcant differences in ER alpha and
ER beta gene expression were found between Sh-treated and vehicle-treated MCF-7
cells (*p < 0.05 vs. control).
Fig. 5. Role of estradiol on activation of estrogen responsive element (ERE) was
assessed by luciferase assay. CHO cells were transfected with a pGL3 reporter
construct containing an ERE linked to luciferase, and incubated with 109 M E2,
109 M ICI or 50 lg/ml Sh afterwards. Reporter gene transactivation was evaluated
2 days after transfection. Luciferase activity induction was measured. Incubation
with Sh or in the presence of ICI resulted in a statistically signiﬁcant decrease in
luciferase activity compared to control (*p < 0.05 Sh vs. control; Sh + ICI vs. control).
Co-incubation of Sh together with E2 further reduced E2 effects on ER transcription
activity (#). Bars represent mean values of three distinct assays. Error bars
represent SD. Experiments were performed in triplicate.
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gen receptor activity.
3.4. Schistosoma haematobium total antigen down-regulates ER alpha
and ER beta
To conﬁrm the involvement of estrogen receptor, expression of
ER alpha and ER beta were analyzed in MCF-7 cells after estradiol,
ICI and Sh treatment. Real-Time PCR analysis for ER alpha, ER
beta, and endogenous control gene GADPH were carried out by
using RNA derived from either vehicle-treated (control), estra-
diol-treated (E2), ICI-treated (ICI) or Sh-treated in MCF-7 cell cul-
tures. Incubation with estrogen clearly increased both ERalpha
and ER beta expression (Fig. 4). Furthermore, both ER isoforms
were down-regulated by Sh treatment in this cell culture, either
alone or in the presence of ICI in comparison to control (Fig. 4).
Interestingly, Sh incubation extensively reduced ER alpha and
ER beta expression, even in the presence of estrogen (*p < 0.05
Sh + E2 vs. E2).
3.5. Schistosoma haematobium repression of ER transcriptional
activity
Nuclear hormone receptors regulate gene expression by inter-
acting directly with DNA response elements. To conﬁrm Sh-medi-
ated down-regulation of ER we carried out transfection of CHO
cells with a reporter gene construct containing an estrogen re-
sponse element (ERE). As shown in Fig. 5, Sh effectively reduced
the transcriptional activity of the ER. When cells are treated
simultaneously with Sh and ICI there is a synergistic effect in the0.00
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Fig. 6. LC–ESI–MS analysis of schistosoma extract (A), serum from a Schistosoma-infected individual (B), and serum from a healthy donor (C). MS spectra of main components
in samples analyzed are given in Supporting Information.
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Table 1
Retention times and m/z values for the four main components identiﬁed by LC–MS
analysis of schistosoma samples.
Component Retention
time (min)
‘‘Duplicated” m/z peaks
detected on negative mode
1 20 610/624
2 22 723/737
3 24 836/850
4 26 949/963
M.C. Botelho et al. / Experimental Parasitology 126 (2010) 526–535 5313.6. Identiﬁcation of new estrogenic molecules in S. haematobium total
antigen
Liquid chromatography coupled to electrospray ionization mass
spectrometry (LC–ESI–MS) was used to provide both a clear dis-
tinction between different samples and a structural identiﬁcation
of their main components. Fig. 6 depicts chromatograms obtained
for biological samples by LC–ESI–MS. As seen, both the schistosoma
extract (Fig. 6A) and the plasma from a Schistosoma-infected indi-
vidual (Fig. 6B) present four main peaks with retention times of
approximately 20, 22, 24 and 26 min. Interestingly, these four peaks
were not observed for the plasma from a healthy donor (Fig. 6C).
Mass spectral analysis, run in the negative mode (i.e., species de-
tected as [M-H]-ions), of the four main components present in both
schistosoma samples revealed that those were species with molec-
ular weights considerably higher than that of estradiol (Table 1).
Moreover, the corresponding m/z peaks seemed duplicated (see
MS spectra on Supporting Information), as each component was
invariably related to two MS peaks, always detected at m/z
([M-H]-) and m/z ([M-H]-) + 14. Species detected after MS2 frag-
mentation of components 1–4, as illustrated in Fig. 7 for component
2 – is themost intense in the schistosoma extract – gave further sup-
port to our previous structural assignment for the four components.4. Discussion
The transcriptional activity of ER is now well described to be
negatively regulated by S. haematobium. The present studies docu-
ment that Sh represses the activation of ER-induced estrogen
responsive element. We also attempted to identify the molecule(s)
in the parasite extract responsible for this effect.
The studies presented in this work indicate that Sh expresses
estrogenic molecules that interact with ER by an intriguing mech-
anism, by down-regulating and repressing ER transcriptional activ-
ity. Our experiments show that there is a direct interaction of Sh,
with ER and that this interaction is ligand-dependent. The ability
of Sh to decrease transcriptional activity by the ER was observed
with a reporter gene construct containing an ERE.
In this manuscript, we present data suggesting that Sh modu-
lates the concentration of ER transcripts in the estrogen responsive
MCF-7 cells, by promoting its down-regulation in a similar way as
the estrogen inhibitor ICI. The hypothesis that this estrogen antag-
onistic effect observed in MCF-7 cells could be due to contamina-
tion of Sh extract by host animal cells that eventually would
interfere with estrogen signaling was ruled out by the procedure
used for Sh isolation. Worms were obtained by perfusion of golden
hamster hepatic portal system, washed in saline solution, counted
and sonicated in order to obtain the antigen. In addition, Sh was
frozen. Therefore, the whole procedure would completely destroy
host cell contamination. We used Real-Time PCR to determine
the expression of ER alpha and ER beta mRNA MCF-7 cells treated
with Sh, E2 and ICI in comparison to vehicle-treated control cells.
Sh clearly down-regulates ER alpha and ER beta. The estrogen
receptor (ER) exists in two isoforms ER alpha and ER beta with a
different distribution in the body and different functions, whichare not clearly identiﬁed yet (Zimmermann and von Angerer,
2007). Physiological effects of estrogen are mediated through both
ER alpha and beta. Importantly, ER alpha- and ER beta-dependent
pathways regulate distinct and largely nonoverlapping sets of
genes. Whereas ER alpha is essential for most of the estrogen-med-
iated increase in gene expression, ER beta mediates the large
majority (nearly 90%) of estrogen-mediated decreases in gene
expression (O’Lone et al., 2007). Additionally, it is possible that
Sh-induced ER alpha and beta down-regulation serves to control
physiological responses in estrogen target tissues, which ulti-
mately serves to limit the expression of estrogen responsive genes
by the parasite.
Interestingly, Sh which enhances the inhibitory effectiveness of
antiestrogens (Figs. 4 and 5), also moderates the activity of estro-
gens because Sh is recruited to the ER even in the presence of estra-
diol, exerting its antagonist actions. Therefore our ﬁndings imply
that Sh dampens the stimulatory response to estradiol.
Our results are consistent with the existence of an estrogenic
molecule that antagonizes the activity of estradiol. We found evi-
dence for this molecule as we identiﬁed and characterized by mass
spectrometry new estrogenic molecules previously unknown,
present in schistosome worm extracts and sera of schistosome in-
fected individuals. The detection method developed by our group
by LC–MS analysis speciﬁc for estrogenic molecules, revealed that
these new estrogens are present in schistosome worm extracts. At
the light of these ﬁndings, we believe that the species detected on
the LC–MS analysis of both the schistosoma extract and the plasma
of a Schistosoma-infected patient were formed by reactions of
estrogen-quinones with DNA. Such reactions might have occurred
directly via Michael addition or indirectly through generation of
reactive oxygen species (ROS) and led to structures (Scheme 1)
compatible with the m/z values observed (Table 1). To conﬁrm this
hypothesis, and given our previous experience in tandem-MS stud-
ies to establish fragmentation mechanisms involving compounds
relevant in other parasitic diseases (Vale et al., 2008a,b, 2009),
we decided to further analyse the serum from a schistosoma-in-
fected individual by LC–MS/MS. Species detected after MS2 frag-
mentation of components 1–4, as illustrated in Fig. 7 for
component 2 – is the most intense in the schistosoma extract –
gave further support to our previous structural assignment for
the four components. We chose component 2 because is the most
intense with a relative abundance of 100%. Indeed, MS2 fragmenta-
tion of component 2 led to ﬁve species that were detected in the
negative mode at m/z values of ca. 595, 621, 677, 695 and 720.
These m/z values are compatible with fragments structures as
those shown on Scheme 2, all of which can be easily derived from
the parental structure 2. Identical analyses was done for the
remaining three components, 1, 3 and 4, whose MS2 spectra are gi-
ven in the Supporting Information and also show fragmentation
patterns that conﬁrm structures above proposed for those
components.
An interpretation of the above ﬁndings was built at the light of
well-established metabolic pathways for estrogens. It is known
from the literature that estradiol is mainly metabolised by (i) oxi-
dation of the hydroxyl function at the C17 position (via steroid
dehydrogenase) to yield estrone, and (ii) hydroxylation via cyto-
chrome P450 enzymes, occurring preferentially on C2, C4 and
C16 (Bolton et al., 1998; Rathahao et al., 2000). When hydroxyl-
ation takes place on the steroid aromatic ring A, catechol-estrogens
are produced (Iverson et al., 1996). Similar transformations can
easily explain the fact that, on schistosoma samples, each compo-
nent was associated to twom/z peaks always differing by 14 a.m.u.
In fact, hydroxylation of both C-2 and C-3 on a steroid ring and fur-
ther oxidation into an estradiol-2,3-quinone (Scheme 3), a phe-
nomenon well described by Iverson and collaborators (1996),
would lead to a mass increase of precisely 14 a.m.u.
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Fig. 7. Mass spectra (MS, (A) and MS2, (B)) for component 2, detected in the LC–MS/MS analysis of Schistosoma-infected human serum. MS and MS2 spectra for components 1,
3 and 4 are given on Supporting Information.
532 M.C. Botelho et al. / Experimental Parasitology 126 (2010) 526–535Furthermore, the proposed molecular structure of these new
estrogenic molecules explains the cellular effects of Sh demon-
strated in this paper. These molecules show a putative binding
afﬁnity with ER and they probably are able to antagonize estradiol
activity and down-regulate ER.
Finally, to our knowledge there are no studies in the literature
reporting the presence of genes involved in estrogen pathways in
S. haematobium. As the genome sequences of the closely related
African schistosome Schistosoma mansoni (Berriman et al., 2009)and the more distantly related Asian species Schistosoma japonicum
(The Schistosoma japonicum Genome Sequencing and Functional
Analysis Consortium, 2009) are now available we can expect that
schistosomes will express all the genes necessary to synthesize
estrogenic molecules. In this regard, it is noteworthy that the geno-
mic information suggests the presence of an integral hypotha-
lamic–pituitary–thyroid in S. japonicum. It was also conﬁrmed
that S. japonicum has receptors for steroid hormones such as pro-
gestin, progesterone and estrogen. In addition it possesses intricate
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M.C. Botelho et al. / Experimental Parasitology 126 (2010) 526–535 533pathways for processing steroid hormones to form other sex hor-
mones. For example, there are putative enzymes present that could
convert the female hormones progesterone and pregnenolone to
estriol, oestrone, androsterone and testosterone. Hence, schisto-
somes might use these pathways during their parasitic existence
(The Schistosoma japonicum Genome Sequencing and Functional
Analysis Consortium, 2009).The observations described in this study assist in deﬁning the
biochemical basis of the selective interactions between Sh and
the ER, and they provide insights into the molecular mechanisms
by which Sh acts to modulate the activity of this steroid hormone
receptor, possibly through the new estrogenic molecules identiﬁed
in the crude parasite extracts. Additional studies addressing the
regulation of expression of these new estrogenic molecules of
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534 M.C. Botelho et al. / Experimental Parasitology 126 (2010) 526–535S. haematobium and their antiestrogenic activity will be important
in further understanding how this parasite infection inﬂuences ERtranscription, as well as the beneﬁt this ER repression may provide
to the parasite.
HO
A
P450
O
A
O
Scheme 3. Hydroxylation of both C-2 and C-3 on a steroid ring and further
oxidation into an estradiol-2,3-quinone.
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